Feasibility and acceptability of FinCare: A personalized online tool for estimating out-of-pocket costs for cancer treatment

• by Carolyn Y. Fang, Amani Boudriga, Amine Raounak, Howard Isenstein, Brian L. Egleston, Erin Tagai, Melissa McShane, Efrat Dotan, Daniel M. Geynisman

• July 14, 2026

Machine learning-driven identification of DLL3 as a molecular target and development of a DLL3-binding cyclic peptide for glioblastoma

• by Dan Xu, Daqing Huang, Zhijie Li, Yan Yan, Zhencun Cui, Zhongfang Zhao, Xiaoju Chen, Maolong Chen, Xiongxiong Liu, Zhaobo Zhou, Qianxi Ni, Taofeng Zhang, Hui Wang, Qi Zeng, Xi’an Xiong, Bin Liu

• July 14, 2026

Surviving CGT's Funding Winter

In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market

• by Alun Evans, James Strachan

• July 15, 2026

• 11 min

Distribution and function of human long-lasting T cells in aging and non-small cell lung cancer

• by Jia Xuan Tan, Hua Run Yu, Yong Gu, Hai Hong

• July 15, 2026